These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 37422876)

  • 1. [Regulatory effect of NF-κB on prostatic hyperplasia: Progress in researches].
    Wang KY; Wu JH
    Zhonghua Nan Ke Xue; 2021 Nov; 27(11):1025-1029. PubMed ID: 37422876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcuma oil ameliorates benign prostatic hyperplasia through suppression of the nuclear factor-kappa B signaling pathway in rats.
    Wang S; Li Y; Li W; Zhang K; Yuan Z; Cai Y; Xu K; Zhou J; Du Z
    J Ethnopharmacol; 2021 Oct; 279():113703. PubMed ID: 33340599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM52 positively mediates NF-κB to promote the growth of human benign prostatic hyperplasia cells through affecting TRAF2 ubiquitination.
    Sun J; Liu P; Mao J; Han W; Jiang X; Gu Y
    Life Sci; 2020 Oct; 259():118380. PubMed ID: 32898524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extract of Celtis choseniana Nakai alleviates testosterone-induced benign prostatic hyperplasia through inhibiting 5α reductase type 2 and the Akt/NF-κB/AR pathway.
    Hong GL; Kim TW; Lee HJ; Kim YJ; Kim KH; Jung JY
    Chin J Nat Med; 2022 Jul; 20(7):518-526. PubMed ID: 35907650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol Attenuates the Proliferation of Prostatic Stromal Cells in Benign Prostatic Hyperplasia by Regulating Cell Cycle Progression, Apoptosis, Signaling Pathways, BPH Markers, and NF- κB Activity.
    Jang J; Song J; Lee J; Moon SK; Moon B
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways.
    Penna G; Fibbi B; Amuchastegui S; Corsiero E; Laverny G; Silvestrini E; Chavalmane A; Morelli A; Sarchielli E; Vannelli GB; Gacci M; Colli E; Maggi M; Adorini L
    Prostate; 2009 Apr; 69(5):480-93. PubMed ID: 19107880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual specificity phosphatase 1 expression inversely correlates with NF-κB activity and expression in prostate cancer and promotes apoptosis through a p38 MAPK dependent mechanism.
    Gil-Araujo B; Toledo Lobo MV; Gutiérrez-Salmerón M; Gutiérrez-Pitalúa J; Ropero S; Angulo JC; Chiloeches A; Lasa M
    Mol Oncol; 2014 Feb; 8(1):27-38. PubMed ID: 24080497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulated CFTR During Aging Contributes to Benign Prostatic Hyperplasia.
    Xie C; Sun X; Chen J; Ng CF; Lau KM; Cai Z; Jiang X; Chan HC
    J Cell Physiol; 2015 Aug; 230(8):1906-15. PubMed ID: 25546515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF/IL-1/NIK/NF-kappa B transduction pathway: a comparative study in normal and pathological human prostate (benign hyperplasia and carcinoma).
    Nuñez C; Cansino JR; Bethencourt F; Pérez-Utrilla M; Fraile B; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Royuela M
    Histopathology; 2008 Aug; 53(2):166-76. PubMed ID: 18752500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of inflammatory responses, apoptosis, and STAT3/NF-κB- and Nrf2-mediated oxidative stress on benign prostatic hyperplasia induced by a high-fat diet.
    Li Y; Shi B; Dong F; Zhu X; Liu B; Liu Y
    Aging (Albany NY); 2019 Aug; 11(15):5570-5578. PubMed ID: 31412319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between IL-6/ERK and NF-κB: a study in normal and pathological human prostate gland.
    Rodríguez-Berriguete G; Prieto A; Fraile B; Bouraoui Y; de Bethencourt FR; Martínez-Onsurbe P; Olmedilla G; Paniagua R; Royuela M
    Eur Cytokine Netw; 2010 Dec; 21(4):241-50. PubMed ID: 21081304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB.
    Jin BR; An HJ
    Aging (Albany NY); 2021 Aug; 13(16):20016-20028. PubMed ID: 34411001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shrinkage of experimental benign prostatic hyperplasia and reduction of prostatic cell volume by a gastrin-releasing peptide antagonist.
    Rick FG; Abi-Chaker A; Szalontay L; Perez R; Jaszberenyi M; Jayakumar AR; Shamaladevi N; Szepeshazi K; Vidaurre I; Halmos G; Krishan A; Block NL; Schally AV
    Proc Natl Acad Sci U S A; 2013 Feb; 110(7):2617-22. PubMed ID: 23359692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia.
    Rick FG; Schally AV; Block NL; Nadji M; Szepeshazi K; Zarandi M; Vidaurre I; Perez R; Halmos G; Szalontay L
    Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3755-60. PubMed ID: 21321192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiome analysis reveals the inducing effect of
    Li J; Li Y; Zhou L; Li H; Wan T; Tang J; Zhou L; Xie H; Wang L
    Virulence; 2024 Dec; 15(1):2313410. PubMed ID: 38378443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
    Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
    J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory Signaling Involved in High-Fat Diet Induced Prostate Diseases.
    Shankar E; Bhaskaran N; MacLennan GT; Liu G; Daneshgari F; Gupta S
    J Urol Res; 2015 Jan; 2(1):. PubMed ID: 26417612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qianliexin capsule exerts anti-inflammatory activity in chronic non-bacterial prostatitis and benign prostatic hyperplasia via NF-κB and inflammasome.
    Zang L; Tian F; Yao Y; Chen Y; Shen Y; Han M; Meng Z; Fan S; Zhang X; Cai T; Gao Q; Zhang Y; Lu J
    J Cell Mol Med; 2021 Jun; 25(12):5753-5768. PubMed ID: 33982874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classical and alternative nuclear factor-κB pathways: a comparison among normal prostate, benign prostate hyperplasia and prostate cancer.
    Cai C; Jiang FN; Liang YX; He HC; Han ZD; Dai QS; Qin GQ; Chen JH; Chen XB; Chen YR; Zeng GH; Zhu JG; Zhong WD
    Pathol Oncol Res; 2011 Dec; 17(4):873-8. PubMed ID: 21499820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Androgen Receptor Antagonist MDV3100 Therapy on Rats With Benign Prostatic Hyperplasia.
    Yang M; Xu Z; Zhuang Z
    Int Neurourol J; 2021 Sep; 25(3):219-228. PubMed ID: 34610715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.